Ebastine for Adjuvant Treatment of Tumor Budding-Positive Liver Cancer After Surgery

NCT07734766 · clinicaltrials.gov ↗

PHASE4

Phase

NOT_YET_RECRUITING

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Hepato Cellular Carcinoma

Interventions

DRUG: Ebastine

Sponsor

Second Affiliated Hospital of Xi'an Jiaotong University